HopeStage
Back to all studies
CompletedNCT01227980

Pexacerfont for Anxiety and Alcohol Craving

About this titleRead the official source — NCT01227980
Medication studyAges 21–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 65 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2010
Recruitment status
Completed
Enrollment listed in the registry
70
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT01227980
Official title
Show the full official title

Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.

Did this study involve medication?

Yes. The study involved medication, including Pexacerfont and Placebo.

Who was this study for?

Listed age limits: 21 years to 65 years.

Want to explore more studies?

Explore studies